---
title: "NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP — DecisionGateway"
description: "India's NPPA capped trade margins on 137 non-scheduled anti-cancer drugs, including patented ones, at 30% of MRP, which companies say has cut prices sharply and"
canonical_url: "https://dgw.tmarket.io/decisions/01a1df49-a451-78f5-afac-5851dd85817f"
meta:
  "og:description": "India's NPPA capped trade margins on 137 non-scheduled anti-cancer drugs, including patented ones, at 30% of MRP, which companies say has cut prices sharply and"
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

**Decision**/Regulate/17 Oct 2026

**Adopted**

# **NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP**

India's NPPA capped trade margins on 137 non-scheduled anti-cancer drugs, including patented ones, at 30% of MRP, which companies say has cut prices sharply and could save patients thousands of crores of rupees.

## **Actors and targets**

Targets 137 गैर-अनुसूचित कैंसर रोधी दवाओंitem30% व्यापार मार्जिन सीमाpolicy

## **Source**

> राष्ट्रीय औषध मूल्य निर्धारण प्राधिकरण (एनपीपीए) ने पेटेंट प्राप्त दवाओं सहित 137 गैर-अनुसूचित कैंसर रोधी दवाओं पर व्यापार मार्जिन को अधिकतम खुदरा मूल्य (एमआरपी) के 30% तक सीमित कर दिया

*pib\_backgrounders · Telegram [ Open post](https://t.me/pib_backgrounders/764)*

## **Not established**

- Date known only to the year

## **Extracted detail**

<dl>

<dt>Decision maker</dt>
<dd>राष्ट्रीय औषध मूल्य निर्धारण प्राधिकरण (एनपीपीए)</dd>

<dt>Sector</dt>
<dd>pharmaceuticals</dd>

<dt>Country</dt>
<dd>India</dd>

</dl>

## **Related decisions**

Same kind only, ranked by embedding similarity to this record.

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,500+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/decisions/01a1df49-a451-78f5-afac-5851dd85817f#webpage","@type":"WebPage","description":"India's NPPA capped trade margins on 137 non-scheduled anti-cancer drugs, including patented ones, at 30% of MRP, which companies say has cut prices sharply and","name":"NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP — DecisionGateway","url":"https://dgw.tmarket.io/decisions/01a1df49-a451-78f5-afac-5851dd85817f","breadcrumb":{"@id":"https://dgw.tmarket.io/decisions/01a1df49-a451-78f5-afac-5851dd85817f#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/decisions/01a1df49-a451-78f5-afac-5851dd85817f"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/decisions/01a1df49-a451-78f5-afac-5851dd85817f#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Feed","item":"https://dgw.tmarket.io/feed","position":2},{"@type":"ListItem","name":"NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP","position":3}]}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.